Gene drives and societal narratives
By Brigitte Nerlich,
Making Science Public
| 08. 21. 2020
A review of nine previous posts about gene drives, most by the same author
Some days ago, I came across an interesting virtual conference (HT @Sarah_A_Hartley) about gene editing which includes a session on ‘societal narratives’. I have written quite a bit about societal narratives of gene editing, but more recently I became involved in the issue of ‘gene drive’, that is, “a system of biased inheritance in which the ability of a genetic element to pass from a parent to its offspring through sexual reproduction is enhanced”. This is a naturally occurring twist in the laws of inheritance that scientists can use (with the help of gene editing) “to develop [artificial] gene-drive modified organisms for public health, conservation, agriculture, and other societal purposes, for example, by suppressing populations of mosquito species that transmit human diseases such as malaria, dengue, Zika, and chikungunya among others” (Gene drives on the horizon, 2016).
I suddenly asked myself: Are there any societal narratives emerging around gene drives? Cloninghas societal narratives, recombinant DNA has societal narratives, genetic engineering has societal narratives (I can’t wait for @matthewcobb’s book about this), genomics has societal narratives, genetic...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...